NCT07134192 Fluorescence-Guided Optimization of Sarcoma Margins
| NCT ID | NCT07134192 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Soft Tissue Sarcoma of the Trunk and Extremities |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2025-09-01 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.
Eligibility Criteria
Inclusion Criteria: * Biopsy verified intermediate-to-high grade sarcoma of theextremity or trunk wall * Age\>18 years old * Tumor operable * Curative intent at time of surgery * Consent of patient Exclusion Criteria: * History of allergic reaction to iodine-containing pharmaceuticals * End-stage renal disease or eGFR \<15 * Patient decision * Lack of capacity * Inoperability
Contact & Investigator
Thomas Baad-Hansen, MD, PhD
PRINCIPAL INVESTIGATOR
Orthopedic Surgical Department, Aarhus University Hospital
Frequently Asked Questions
Who can join the NCT07134192 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Soft Tissue Sarcoma of the Trunk and Extremities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07134192 currently recruiting?
Yes, NCT07134192 is actively recruiting participants. Contact the research team at chrkve@rm.dk for enrollment information.
Where is the NCT07134192 trial being conducted?
This trial is being conducted at Aarhus N, Denmark, Copenhagen, Denmark.
Who is sponsoring the NCT07134192 clinical trial?
NCT07134192 is sponsored by University of Aarhus. The principal investigator is Thomas Baad-Hansen, MD, PhD at Orthopedic Surgical Department, Aarhus University Hospital. The trial plans to enroll 90 participants.